RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Eli Lilly
E

Eli Lilly portfolio

Eli Lilly has 21 portfolio companies on record at Recent Funding, with 8 investments in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 21.
Deals, last 12 months: 8.
Rounds led: 1 of 18.
Capital in their rounds: $1.82B.
Latest deal: Oyster Therapeutics · Nov 10, 2026.
About this page

It led 1 of the 18 rounds it joined. Its most recent investment on record is Oyster Therapeutics's $60M Series A round in November 2026, alongside Global Brain Corporation, 4BIO Capital, Mass General Brigham Ventures and 5 others. By category, its portfolio leans toward Health and bio (21) and Robotics and hardware (2). It has co-invested with Mission BioCapital, Pfizer Venture Investments and Novo Holdings, most often Mission BioCapital (3 rounds).

What Eli Lilly invests in

Eli Lilly recent investments

How Eli Lilly invests

StageDealsCapital in rounds
Series A 8 44%$565.17M
Series B+ 8 44%$1.21B
Seed 2 11%$47M
YearDealsCapital in rounds
2022 1 6%$64M
2023 2 11%$255M
2024 2 11%$138.17M
2025 6 33%$397M
2026 7 39%$965M

Eli Lilly portfolio companies

CompanyRound with Eli LillyTotal raisedLatest raise
OOyster Therapeutics
Health and bio
Series A · $60M$60MNov 10, 2026
Series A
TThatch
Fintech
Series B+ · $108M$186MSep 15, 2026
Series B+
CCloverleaf Bio
Health and bio
Seed · $33M$33MSep 8, 2026
Seed
OOura
Health and bio
Series B+ · lead$1.24BJul 15, 2026
Series B+
AAdvanCell
Health and bio
Series B+ · $315M$439.5MJul 15, 2026
Series B+
TTRIMTECH Therapeutics
Health and bio
Seed · $14M$45MJun 23, 2026
Seed
NNewLimit
Health and bio
Series B+ · $435M$650MJun 2, 2026
Series B+
EExcelsior Sciences
Health and bio
Series A · $70M$165MDec 3, 2025
Series A
TTherini Bio
Health and bio
Series A · $39M$56MMay 21, 2026
Series A
AAugustine Therapeutics
Health and bio
Series A · $85M$103.17MMar 24, 2025
Series A
AAmpersand Biomedicines
Health and bio
Series B+ · $65M$65MMar 19, 2025
Series B+
OOrbis Medicines
Health and bio
Series A · $93M$121MJan 6, 2025
Series A
MMyricx Bio
Health and bio
Series A · $120M$120MJul 8, 2024
Series A
MMariana Oncology
Health and bio
Series B+ · $175M$175MSep 7, 2023
Series B+
CCrossbow Therapeutics
Health and bio
Series A · $80M$157MMar 26, 2026
Series B+
AArkuda Therapeutics
Health and bio
Series B+ · $64M$108MFeb 10, 2022
Series B+
FFlare Therapeutics
Health and bio
backer$167MJun 30, 2026
Series B+
GGrove Biopharma
Health and bio
backer$30MApr 23, 2025
Series A
PPersist AI
Health and bio
backer$16.5MMay 19, 2025
Series A
VViaNautis
Health and bio
backer$25MOct 31, 2024
Series A
SSeawolf Therapeutics
Health and bio
backer$100MNov 16, 2026
Seed

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 18 rounds on Recent Funding that name Eli Lilly. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Eli Lilly, which is a subset of its real portfolio. API: /api/v1/investors/eli-lilly (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy